Involvement of the Na+ ,K+ -ATPase isoforms in control of cerebral perfusion

Exp Physiol. 2019 Jul;104(7):1023-1028. doi: 10.1113/EP087519. Epub 2019 Mar 7.

Abstract

New findings: What is the topic of this review? In this review, we consider the role of the Na+ ,K+ -ATPase in cerebrovascular function and how it might be changed in familial hemiplegic migraine type 2 (FHM2). The primary focus is involvement of the Na+ ,K+ -ATPase isoforms in regulation of cerebrovascular tone. What advances does it highlight? In this review, we discuss three overall distinct mechanisms whereby the Na+ ,K+ -ATPase might be capable of regulating cerebrovascular tone. Furthermore, we discuss how changes in the Na+ ,K+ -ATPase in cerebral arteries might affect brain perfusion and thereby be involved in the pathology of FHM2.

Abstract: Familial hemiplegic migraine type 2 (FHM2) has been characterized by biphasic changes in cerebral blood flow during a migraine attack, with initial hypoperfusion followed by abnormal hyperperfusion of the affected hemisphere. We suggested that FHM2-associated loss-of-function mutation(s) in the Na+ ,K+ -ATPase α2 isoform might be responsible for these biphasic changes in several ways. We found that reduced expression of the α2 isoform leads to sensitization of the contractile machinery to [Ca2+ ]i via Src kinase-dependent signal transduction. This change in sensitivity might be the underlying mechanism for both abnormally potentiated vasoconstriction and exaggerated vasorelaxation. Moreover, the functional significance of the Na+ ,K+ -ATPase α2 isoform in astrocytes provides for the possibility of elevated extracellular potassium signalling from astrocytic endfeet to the vascular wall in neurovascular coupling.

Keywords: Na+,K+-ATPase; blood vessels; neurovascular coupling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / enzymology
  • Cerebrovascular Circulation / drug effects
  • Cerebrovascular Circulation / physiology*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Isoenzymes / chemistry
  • Isoenzymes / physiology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology*
  • Neurovascular Coupling / drug effects
  • Neurovascular Coupling / physiology*
  • Ouabain / pharmacology
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Sodium-Potassium-Exchanging ATPase / chemistry
  • Sodium-Potassium-Exchanging ATPase / physiology*

Substances

  • Enzyme Inhibitors
  • Isoenzymes
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase